That’s a wrap on an incredible week at OTS2025 in Budapest! The event was filled with inspiring talks and meaningful conversations that left us energized about the future of oligonucleotide therapeutics. Next stop: San Diego for the 16th World ADC in two weeks! Synoligo is proud to be among the select few companies, out of […]
Read more »
As a sponsor of the 21st Annual Meeting of the Oligonucleotide Therapeutics Society, Synoligo is eager to engage with the researchers and experts who are shaping the future of oligo therapeutics, including those working on antisense, siRNA, immunostimulatory, and aptamers. Stop by Booth#27 to learn how our services are designed to accelerate your process and […]
We are heading back to Boston! The Synoligo team is excited to exhibit at the American Society of Human Genetics Annual Meeting next month. We are bringing our advanced oligo synthesis capabilities to diagnostic companies looking for a quality partner. Meet our BD Director, Marc Beal, at Booth#560 to discuss your project. Plus, take advantage […]
The RNA Leaders USA Congress continues to grow each year, and Synoligo is proud to support its expansion as a sponsor in 2025. Our team will be on site to connect, exchange insights, and explore emerging innovations in the RNA space. We hope to meet you at our booth#23! Check out our therapeutic oligos page: […]
Synoligo is at the 5th Oligonucleotides for CNS Summit! As experts in synthesizing custom ASOs, siRNAs, miRNAs, and saRNAs, we are ready to contribute our knowledge and expertise to help optimize delivery and reduce toxicity for oligos treating CNS diseases. Connect with us to discuss how we can help with your current or future project! […]
The 4th Oligonucleotides Analytical Development and CMC Summit is happening now, and our team is there! We’re diving deep into the conversations that matter, tackling the unique challenges in oligo analytical development and CMC scale-up. At Synoligo, we know flexibility is key to your success. Whether you need tubes for a single experiment or plates […]
Synoligo Biotechnologies Launches Cutting-Edge E-commerce Platform for Oligonucleotide Synthesis, Empowering Researchers with Streamlined Access Morrisville, North Carolina – July 23, 2025 – Synoligo Biotechnologies Inc., a leader in custom oligonucleotide synthesis, has announced the launch of its new e-commerce website, transforming the way researchers access high-quality oligonucleotides. The platform addresses critical needs in the scientific […]
The 6th RNA Editing Summit is just around the corner, and Synoligo is excited to sponsor this premier gathering of scientific leaders and innovators. From breakthrough editing technologies to strategies for advancing programs toward the clinic, the summit will also unveil never-before-seen clinical data that could shape the next wave of therapeutic innovation. Mark your […]
The RNA Therapeutics: From Concept to Clinic Conference was a tremendous success last year, and we are thrilled to return as a sponsor. This year’s symposium promises another opportunity to bring together scientists, clinicians, and innovators from across sectors. Synoligo looks forward to engaging with attendees and offering our expertise in custom oligonucleotide synthesis.
As a sponsor of the 4th Dutch Antisense Therapeutics Symposium, Synoligo reaffirms its commitment to advancing oligonucleotide innovation. Representing us at the symposium, Dr. John Randolph will engage with fellow experts to explore emerging strategies and share how Synoligo’s manufacturing capabilities can support cutting-edge research across the Netherlands.
SynOligo Biotechnologies and Lumiphore Announce a Partnership to Provide [Time-Resolved] Luminescent Oligos and Assays for the Nucleic Acid Amplification Testing Market (NAAT) The partnership aims to provide game-changing luminescent lanthanide-based oligo probes for diagnostics and life science research applications. Morrisville, NC / Berkeley, CA, May 19th, 2025. SynOligo Biotechnologies Inc. and Lumiphore Inc. announced they […]
The RNA Society is celebrating its 30th Annual Meeting in San Diego, and we are excited to be part of it as an exhibitor! Dr. John Randolph will be representing Synoligo and connecting with the RNA research community to share our oligonucleotide manufacturing capabilities. We look forward to seeing you there!
Synoligo is proud to support TIDES USA, one of North America’s premier conferences for oligonucleotide and peptide therapeutics. This event aligns with our core belief in the power of collaboration and knowledge sharing to drive innovation, from early discovery to clinical application. Visit us at booth #313!
Synoligo is committed to staying at the forefront of RNA innovation. That’s why we’re proud to sponsor the 4th Circular & saRNA Therapeutics Summit. Events like this are vital for sharing ideas and driving forward the next generation of RNA therapeutics. Mark your calendar!
Synoligo is excited to announce our sponsorship of the 4th Annual Novel Conjugates Summit next month. Our team is prepared to engage with industry experts and showcase how our oligo conjugation services can help drive innovation in targeted cancer therapies. Join us! https://lnkd.in/giCX9Fgn
Synoligo is proud to sponsor the 10th Annual OPT Congress, where innovation in oligonucleotide therapies takes center stage! This year’s program highlights emerging oligo modalities and cutting-edge approaches to designing targeted treatments. We hope to see you there!
This year, we’re back as a sponsor for the RNA Leaders Europe Congress! Our team is eager to connect with researchers and industry leaders spanning the entire RNA spectrum, including oligo-based RNA, next-gen RNA, and mRNA vaccines and therapeutics. Let’s drive RNA innovation together!
Looking ahead to January 2025, Synoligo is proud to sponsor our first event, the 6th Annual RNAi-Based Therapeutics Summit! Our team is eager to connect with leading experts and delve into advancements in chemical modifications for the next-generation.
What an incredible year it has been! Synoligo is closing 2024 with one final event, the 5th Annual Genome Editing Therapeutic Summit. We are looking forward to explore the latest advancements in cutting-edge therapies and precision #genome editing techniques that drive #innovation in drug development for #genetic diseases.
Morrisville, North Carolina, October 29, 2024 — Synoligo Biotechnologies Inc., a Contract Research and Development Organization (CRDO) based in Research Triangle Park, announced the expansion of its production capabilities with the addition of a new 5,000 square foot facility dedicated to high-throughput custom oligonucleotide synthesis. This expansion marks a significant milestone in Synoligo’s rapid growth […]
Synoligo is pleased to continue our sponsorship of the @Oligonucleotide Therapeutics Society meeting in Montreal this year. This meeting is a great opportunity to explore the progress of #oligonucleotides from basic research to therapeutic development. Save the date! https://www.2024oligomeeting.com/
Another eventful week ahead for the Synoligo team! We’re excited to attend the Genome Engineering: #CRISPR Frontiers Meeting from August 27th-31st. We look forward to exploring the latest advancements in #genome engineering and discovering new ways we can contribute! #cshlcrispr24 #gRNA
The Oligonucleotides CMC & Analytical Development Summit is returning for its 3rd year on August 27-29. Over 100 industry leaders will come together to discuss regulatory requirements, CMC, and analytical strategies to ensure the scalability and manufacturability of high-quality products. Synoligo is excited to sponsor and participate in these vital discussions.
Synoligo will be sponsoring RNA Leaders US Congress, taking place next month. Get ready for inspiring talks, networking opportunities and so much more. See you there! https://informaconnect.com/rna-leaders-usa/#rnaleaders #mRNA #RNAi #biopharma #rnatherapeutics
Get access to technical content, promotions, upcoming events and press release.
